WILEY

KNOWLEDGE FOR GENERATIONS

WILEY - KNOWLEDGE FOR GENERATIONS

United States Change Location

cart.gif CART |  MY ACCOUNT |  CONTACT US |  HELP    
Wiley.com
Stem Cells: Nuclear Reprogramming and Therapeutic Applications, Novartis Foundation Symposium, No. 265 (0470091436) cover image
Stem Cells: Nuclear Reprogramming and Therapeutic Applications, Novartis Foundation Symposium, No. 265
ISBN: 978-0-470-09143-2
Hardcover
230 pages
May 2005
US $195.00 Add to Cart

This price is valid for United States. Change location to view local pricing and availability.

This is a Print-on-Demand title. It will be printed specifically to fill your order. Please allow an additional 5-6 days delivery time. The book is not returnable.
Other Available Formats: E-Book

  • Description
  • Table of Contents
  • Reviews
Chair's Introduction (John Gearhart).

What is a stem cell ?  Discussion (Davor Solter).

Bone-marrow derived hepatocytes - Discussion (Markus Grompe).

Normal and neoplastic stem cells - Discussion (Irvin L. Weissman).

Multipotent adult progenitor cells: an update - Discussion (Catherine A. Verfaillie).

Neural progenitor cells of the adult brain - Discussion (Steven A. Goldman and Fraser Sim).

Stem cells in the brain - General Discussion I.

Embryonic stem cells: a perspective - Discussion (Martin Evans).

Nuclear cloning, epigenetic reprogramming and cellular differentiation - Discussion (Rudolf Jaenisch, Konrad Hochedlinger and Kevin Eggan).

General Discussion II.

Nuclear reprogramming by xenopus oocytes - Discussion (J.B. Gordon, J.A. Byrne and S. Simonsson).

Cardiac stem cells and myocardial regeneration - Discussion (Bernardo Nadal-Ginard, Perio Anversa, Jan Kajstura and Annarosa Leri).

Genenration of insulin-producing cells from stem cells - Discussion (Bernat Soria, Enrique Roche, Juan A. Reig and Franz Martin).

Cell therapy for Parkinson's disease: problems and prospects - Discussion (Anders Bjorklund).

Ethical (and political) issues in research with human stem cells - Discussion (Thomas H. Murray).

The regulatory environment - final discussion.

Index of contributors.

Subject index.

Share This    Printer-ready version